BEAM
Price
$26.73
Change
-$1.23 (-4.40%)
Updated
Oct 27 closing price
Capitalization
2.83B
13 days until earnings call
Intraday Buy/Sell Signals
PCVX
Price
$44.57
Change
+$2.34 (+5.54%)
Updated
Oct 27 closing price
Capitalization
5.48B
13 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

BEAM vs PCVX

Header iconBEAM vs PCVX Comparison
Open Charts BEAM vs PCVXBanner chart's image
Beam Therapeutics
Price$26.73
Change-$1.23 (-4.40%)
Volume$3.04M
Capitalization2.83B
Vaxcyte
Price$44.57
Change+$2.34 (+5.54%)
Volume$1.33M
Capitalization5.48B
BEAM vs PCVX Comparison Chart in %
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PCVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. PCVX commentary
Oct 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and PCVX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 28, 2025
Stock price -- (BEAM: $26.73 vs. PCVX: $44.57)
Brand notoriety: BEAM and PCVX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 111% vs. PCVX: 69%
Market capitalization -- BEAM: $2.83B vs. PCVX: $5.48B
BEAM [@Biotechnology] is valued at $2.83B. PCVX’s [@Biotechnology] market capitalization is $5.48B. The market cap for tickers in the [@Biotechnology] industry ranges from $108.04B to $0. The average market capitalization across the [@Biotechnology] industry is $2.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whilePCVX’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • PCVX’s FA Score: 0 green, 5 red.
According to our system of comparison, PCVX is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 3 TA indicator(s) are bullish while PCVX’s TA Score has 6 bullish TA indicator(s).

  • BEAM’s TA Score: 3 bullish, 5 bearish.
  • PCVX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, PCVX is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а -12.70% price change this week, while PCVX (@Biotechnology) price change was +3.89% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.69%. For the same industry, the average monthly price growth was +11.04%, and the average quarterly price growth was +64.46%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 10, 2025.

PCVX is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (-0.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PCVX($5.48B) has a higher market cap than BEAM($2.83B). BEAM YTD gains are higher at: 7.782 vs. PCVX (-45.553). BEAM has higher annual earnings (EBITDA): -414.33M vs. PCVX (-584.35M). PCVX has more cash in the bank: 1.66B vs. BEAM (1.15B). PCVX has less debt than BEAM: PCVX (85.8M) vs BEAM (155M). BEAM has higher revenues than PCVX: BEAM (60.3M) vs PCVX (0).
BEAMPCVXBEAM / PCVX
Capitalization2.83B5.48B52%
EBITDA-414.33M-584.35M71%
Gain YTD7.782-45.553-17%
P/E RatioN/AN/A-
Revenue60.3M0-
Total Cash1.15B1.66B69%
Total Debt155M85.8M181%
TECHNICAL ANALYSIS
Technical Analysis
BEAMPCVX
RSI
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
73%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
N/A
Bullish Trend 1 day ago
76%
MACD
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
73%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
77%
Advances
ODDS (%)
Bullish Trend 8 days ago
78%
Bullish Trend 1 day ago
79%
Declines
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 11 days ago
77%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 1 day ago
86%
Aroon
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PCVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
APHMX49.740.38
+0.77%
Artisan Mid Cap Institutional
SCWCX62.010.34
+0.55%
American Funds SMALLCAP World C
HMVYX18.55N/A
N/A
Hartford MidCap Value Y
NWHHX16.54N/A
N/A
Nationwide Bailard Cogntv Val Instl Svc
NUESX23.88N/A
N/A
Northern US Quality ESG K

PCVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PCVX has been loosely correlated with KYMR. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if PCVX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCVX
1D Price
Change %
PCVX100%
+5.54%
KYMR - PCVX
47%
Loosely correlated
+3.91%
NUVL - PCVX
45%
Loosely correlated
+4.63%
IDYA - PCVX
45%
Loosely correlated
+10.93%
BEAM - PCVX
44%
Loosely correlated
-4.40%
MRNA - PCVX
44%
Loosely correlated
-0.30%
More